Crystal structure of the endogenous agonist-bound prostanoid receptor EP3

被引:0
|
作者
Kazushi Morimoto
Ryoji Suno
Yunhong Hotta
Keitaro Yamashita
Kunio Hirata
Masaki Yamamoto
Shuh Narumiya
So Iwata
Takuya Kobayashi
机构
[1] Kyoto University,Department of Cell Biology, Graduate School of Medicine
[2] Konoe-cho,Japan Agency for Medical Research and Development (AMED)
[3] Yoshida,Medical Innovation Center, Graduate School of Medicine
[4] Core Research for Evolutional Science and Technology (CREST),Department of Medical Chemistry
[5] RIKEN SPring-8 Center,undefined
[6] Sayo-cho,undefined
[7] Kyoto University,undefined
[8] Kansai Medical University,undefined
来源
Nature Chemical Biology | 2019年 / 15卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Prostanoids are a series of bioactive lipid metabolites that function in an autacoid manner via activation of cognate G-protein-coupled receptors (GPCRs). Here, we report the crystal structure of human prostaglandin (PG) E receptor subtype EP3 bound to endogenous ligand PGE2 at 2.90 Å resolution. The structure reveals important insights into the activation mechanism of prostanoid receptors and provides a molecular basis for the binding modes of endogenous ligands.
引用
收藏
页码:8 / 10
页数:2
相关论文
共 50 条
  • [41] The Roles Played by FP/EP3 Receptors During Pressure-lowering in Mouse Eyes Mediated by a Dual FP/EP3 Receptor Agonist
    Yamagishi-Kimura, Reiko
    Honjo, Megumi
    Aihara, Makoto
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (02)
  • [42] NF-YC Functions as a Corepressor of Agonist-bound Mineralocorticoid Receptor
    Murai-Takeda, Ayano
    Shibata, Hirotaka
    Kurihara, Isao
    Kobayashi, Sakiko
    Yokota, Kenichi
    Suda, Noriko
    Mitsuishi, Yuko
    Jo, Rie
    Kitagawa, Hirochika
    Kato, Shigeaki
    Saruta, Takao
    Itoh, Hiroshi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (11) : 8084 - 8093
  • [43] Impairment of working memory induced by Δ8-tetrahydrocannabinol is due to the activation of prostanoid EP3 receptor in rats
    Nobe, S
    Yamaguchi, T
    Watanabe, S
    Yamamoto, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 233P - 233P
  • [44] Targeting the EP3 receptor to combat pain
    Harrison Charlotte
    Nature Reviews Drug Discovery, 2013, 12 (9) : 666 - 666
  • [45] Subcellular localisation of agonist-bound inhibitory adenosine receptor (AR) subtypes
    Martin, AF
    Ferguson, G
    Watterson, KR
    Palmer, TM
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (04) : 573 - 573
  • [46] Role of prostanoid EP3/1 receptors in mechanisms of emesis and defaecation in ferrets
    Kan, Kelvin K. W.
    Wai, Man K.
    Jones, Robert L.
    Rudd, John A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 803 : 112 - 117
  • [47] GR63799X - A NOVEL PROSTANOID WITH SELECTIVITY FOR EP3 RECEPTORS
    BUNCE, KT
    CLAYTON, NM
    COLEMAN, RA
    COLLINGTON, EW
    FINCH, H
    HUMPHRAY, JM
    HUMPHREY, PPA
    REEVES, JJ
    SHELDRICK, RLG
    STABLES, R
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1991, 21 : 379 - 382
  • [48] Fluorescent Human EP3 Receptor Antagonists
    Tomasch, Miriam
    Schwed, J. Stephan
    Kuczka, Karina
    dos Santos, Sascha Meyer
    Harder, Sebastian
    Nuesing, Rolf M.
    Paulke, Alexander
    Stark, Holger
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (09): : 774 - 779
  • [49] Distinct conformational changes in activated agonist-bound and agonist-free glycine receptor subunits
    Pless, Stephan A.
    Lynch, Joseph W.
    JOURNAL OF NEUROCHEMISTRY, 2009, 108 (06) : 1585 - 1594
  • [50] Immunolocalization of the prostaglandin EP3 receptor.
    Lijun, M
    McKanna, JA
    Breyer, MD
    Breyer, RM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1926 - A1926